Key result
Frail older hypertensive patients had a higher risk of all-cause mortality regardless of blood pressure levels, with those having systolic blood pressure <140 mmHg and frailty showing a 4.72-fold higher risk compared to non-frail patients with systolic blood pressure <140 mmHg.
Why the study?
Optimal blood pressure targets for older persons with frailty remain controversial due to limited evidence regarding the relationship between blood pressure level and prognosis by frailty status.
Does frailty status modify the association between systolic blood pressure levels and all-cause mortality in older hypertensive patients?
Cohort (n=535)
Yes
Does frailty status modify the association between systolic blood pressure levels and all-cause mortality in older hypertensive patients?
Frailty status modifies the prognostic benefit of strict blood pressure control (<140 mmHg) in older hypertensive patients, with survival benefits observed only in non-frail individuals.
Answers are grounded in this paper and cite their sources.
Supports frailty screening for prognosis in older hypertensives; leaves open optimal BP targets in this subgroup.
Antihypertensive therapy is pivotal for reducing cardiovascular events. The 2019 Guidelines for the Management of Hypertension set a target blood pressure (BP) of <140/90 mmHg for persons older than 75 years of age. Optimal BP levels for older persons with frailty, however, are controversial because evidence for the relationship between BP level and prognosis by frailty status is limited. Here, we evaluated the relationship between systolic BP and frailty status with all-cause mortality in ambulatory older hypertensive patients using data from the Nambu Cohort study. A total of 535 patients (age 78 [70-84] years, 51% men, 37% with frailty) were prospectively followed for a mean duration of 41 (34-43) months. During the follow-up period, 49 patients died. Mortality rates stratified by systolic BP and frailty status were lowest in patients with systolic BP < 140 mmHg and non-frailty, followed by those with systolic BP ≥ 140 mmHg and non-frailty. Patients with frailty had the highest mortality regardless of the BP level. The adjusted hazard ratios (95% confidence intervals) of each category for all-cause mortality were as follows: ≥140 mmHg/Non-frailty 3.19 (1.12-11.40), <140 mmHg/Frailty 4.72 (1.67-16.90), and ≥140 mmHg/Frailty 3.56 (1.16-13.40) compared with <140 mmHg/Non-frailty as a reference. These results indicated that frail patients have a poor prognosis regardless of their BP levels. Non-frail patients, however, with systolic BP levels <140 mmHg had a better prognosis. Frailty may be a marker to differentiate patients who are likely to gain benefit from antihypertensive medication among older hypertensives.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2021) conducted a cohort in Hypertension in older adults (n=535). Frailty with systolic blood pressure <140 mmHg vs. Non-frailty with systolic blood pressure <140 mmHg was evaluated on All-cause mortality (HR 4.72, 95% CI 1.67-16.90). Frail older hypertensive patients had a higher risk of all-cause mortality regardless of blood pressure levels, with those having systolic blood pressure <140 mmHg and frailty showing a 4.72-fold higher risk compared to non-frail patients with systolic blood pressure <140 mmHg.
Synapse has enriched 10 related papers. Consider them for comparative context: